Back to 
MOORE CAPITAL MANAGEMENT, LP
MOORE CAPITAL MANAGEMENT, LP
UTHR
Showing 0 of 7 quarters
Position history for MOORE CAPITAL MANAGEMENT, LP's holdings in UNITED THERAPEUTICS CORP DEL
No. Moore Capital Management exited its UTHR (United Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 89,979 shares worth $18.8M. Moore Capital Management first reported UTHR in Q2 2021 and held it in 6 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.